Skip to Content
AP National Business

Oncternal Therapeutics: Q4 Earnings Snapshot

KION
By
Published 1:21 PM

SAN DIEGO (AP) — SAN DIEGO (AP) — Oncternal Therapeutics, Inc. (ONCT) on Thursday reported a loss of $11.4 million in its fourth quarter.

The San Diego-based company said it had a loss of 20 cents per share.

The biopharmaceutical company posted revenue of $171,000 in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $372,000.

For the year, the company reported a loss of $44.2 million, or 84 cents per share. Revenue was reported as $1.5 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ONCT at https://www.zacks.com/ap/ONCT

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

Related Articles

BE PART OF THE CONVERSATION

KION 46 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content